Pharma Mar SA
OTC:PHMMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharma Mar SA
OTC:PHMMF
|
ES |
|
Lithium Americas Corp
TSX:LAC
|
CA |
|
Fortescue Metals Group Ltd
ASX:FMG
|
AU |
|
G
|
Grenergy Renovables SA
XMUN:5GR
|
ES |
|
N
|
NOS SGPS SA
ELI:NOS
|
PT |
|
Drone Delivery Canada Corp
XTSX:FLT
|
CA |
|
R
|
RS Automation Co Ltd
KOSDAQ:140670
|
KR |
|
M
|
Mineral Resources Ltd
OTC:MALRF
|
AU |
|
S
|
Surapon Foods PCL
SET:SSF
|
TH |
|
F
|
Franchise Global Health Inc
XTSX:FGH
|
CA |
|
G
|
Goldman Sachs Group Inc
XMUN:GOS
|
US |
|
G
|
GBK Beteiligungen AG
XMUN:GBQ
|
DE |
|
New York Times Co
NYSE:NYT
|
US |
|
M
|
Microsoft Corp
MIL:1MSFT
|
US |
|
Hitech Group Australia Ltd
ASX:HIT
|
AU |
|
Tsingtao Brewery Co Ltd
F:TSI
|
CN |
|
Wise Group AB
STO:WISE
|
SE |
|
Blueport Acquisition Ltd
NASDAQ:BPAC
|
US |
|
Rentokil Initial PLC
LSE:RTO
|
UK |
|
Carmila SA
PAR:CARM
|
FR |
|
Ackermans & Van Haaren NV
XBRU:ACKB
|
BE |
|
I
|
Intrum AB
F:IJU
|
SE |
|
M
|
Microalliance Group Inc
OTC:MALG
|
CN |
|
5
|
51Talk Online Education Group
F:C4G0
|
SG |
Wall St Price Targets
PHMMF Price Targets Summary
Pharma Mar SA
According to Wall Street analysts, the average 1-year price target for PHMMF is 115.76 USD with a low forecast of 71.74 USD and a high forecast of 148.79 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHMMF's stock price target?
Price Target
115.76
USD
According to Wall Street analysts, the average 1-year price target for PHMMF is 115.76 USD with a low forecast of 71.74 USD and a high forecast of 148.79 USD.
What is the Revenue forecast for Pharma Mar SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for Pharma Mar SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is 17%.
What is the Operating Income forecast for Pharma Mar SA?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is 27%.
What is the Pre-Tax Income forecast for Pharma Mar SA?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 48%.
What is the Net Income forecast for Pharma Mar SA?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 8 years is 19%.
